Viewing Study NCT02639260


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-05-18 @ 12:46 AM
Study NCT ID: NCT02639260
Status: COMPLETED
Last Update Posted: 2023-02-24
First Post: 2015-12-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases
Sponsor:
Organization: